These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 28910973

  • 1. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
    Wang J, Xu J, Xing G.
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep 01; 49(9):771-779. PubMed ID: 28910973
    [Abstract] [Full Text] [Related]

  • 2. Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway.
    Ying X, Huang A, Xing Y, Lan L, Yi Z, He P.
    Sci China Life Sci; 2017 Apr 01; 60(4):417-428. PubMed ID: 28251459
    [Abstract] [Full Text] [Related]

  • 3. Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.
    Hu M, Peng S, He Y, Qin M, Cong X, Xing Y, Liu M, Yi Z.
    Oncotarget; 2015 Jun 20; 6(17):15348-61. PubMed ID: 25915156
    [Abstract] [Full Text] [Related]

  • 4. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
    Wang J, Zhang L, Chen G, Zhang J, Li Z, Lu W, Liu M, Pang X.
    Breast Cancer Res Treat; 2014 Nov 20; 148(2):279-89. PubMed ID: 25301089
    [Abstract] [Full Text] [Related]

  • 5. Lycorine inhibits cell proliferation and induced oxidative stress-mediated apoptosis via regulation of the JAK/STAT3 signaling pathway in HT-3 cells.
    Shang H, Jang X, Shi L, Ma Y.
    J Biochem Mol Toxicol; 2021 Oct 20; 35(10):e22882. PubMed ID: 34558146
    [Abstract] [Full Text] [Related]

  • 6. Identification of molecular anti-metastasis mechanisms of lycorine in colorectal cancer by RNA-seq analysis.
    Gao L, Feng Y, Ge C, Xu X, Wang S, Li X, Zhang K, Wang C, Dai F, Xie S.
    Phytomedicine; 2021 May 20; 85():153530. PubMed ID: 33761445
    [Abstract] [Full Text] [Related]

  • 7. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
    Liu CY, Su JC, Ni MH, Tseng LM, Chu PY, Wang DS, Tai WT, Kao YP, Hung MH, Shiau CW, Chen KF.
    Breast Cancer Res Treat; 2014 Jul 20; 146(1):71-84. PubMed ID: 24903225
    [Abstract] [Full Text] [Related]

  • 8. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
    Shen J, Zhang T, Cheng Z, Zhu N, Wang H, Lin L, Wang Z, Yi H, Hu M.
    J Exp Clin Cancer Res; 2018 Jul 17; 37(1):157. PubMed ID: 30016965
    [Abstract] [Full Text] [Related]

  • 9. Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade.
    Wang C, Wang Q, Li X, Jin Z, Xu P, Xu N, Xu A, Xu Y, Zheng S, Zheng J, Liu C, Huang P.
    Biochem Biophys Res Commun; 2017 Jan 29; 483(1):197-202. PubMed ID: 28042037
    [Abstract] [Full Text] [Related]

  • 10. Lycorine inhibits melanoma A375 cell growth and metastasis through the inactivation of the PI3K/AKT signaling pathway.
    Jiang QQ, Liu WB.
    Med Sci (Paris); 2018 Oct 29; 34 Focus issue F1():33-38. PubMed ID: 30403172
    [Abstract] [Full Text] [Related]

  • 11. Lycorine inhibits melanoma cell migration and metastasis mainly through reducing intracellular levels of β-catenin and matrix metallopeptidase 9.
    Zhang P, Zhang M, Yu D, Liu W, Hu L, Zhang B, Zhou Q, Cao Z.
    J Cell Physiol; 2019 Jul 29; 234(7):10566-10575. PubMed ID: 30565685
    [Abstract] [Full Text] [Related]

  • 12. Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts in vitro cytostatic effects in human colorectal cancer via activating the ROS/p38 and AKT signaling pathways.
    Zhang P, Yuan X, Yu T, Huang H, Yang C, Zhang L, Yang S, Luo X, Luo J.
    Oncol Rep; 2021 Apr 29; 45(4):. PubMed ID: 33649853
    [Abstract] [Full Text] [Related]

  • 13. Lycorine (Lycoris radiata)-a unique natural medicine on breast cancer.
    Xue Q, Wang B, Feng J, Li C, Yu M, Zhao Y, Qi Z.
    J Cell Mol Med; 2024 Aug 29; 28(16):e70032. PubMed ID: 39175104
    [Abstract] [Full Text] [Related]

  • 14. Lycorine induces cell death in MM by suppressing Janus Kinase/signal transducer and activator of transcription via inducing the expression of SOCS1.
    Jin Z, Zhou S, Zhang Y, Ye H, Jiang S, Yu K, Ma Y.
    Biomed Pharmacother; 2016 Dec 29; 84():1645-1653. PubMed ID: 27847203
    [Abstract] [Full Text] [Related]

  • 15. Icariside I reduces breast cancer proliferation, apoptosis, invasion, and metastasis probably through inhibiting IL-6/STAT3 signaling pathway.
    Hou M, Li H, He T, Hui S, Dai W, Hou X, Zhao J, Zhao J, Wen J, Kan W, Xiao X, Zhan X, Bai Z.
    J Pharm Pharmacol; 2024 May 03; 76(5):499-513. PubMed ID: 37971302
    [Abstract] [Full Text] [Related]

  • 16. Verbascoside Inhibits Glioblastoma Cell Proliferation, Migration and Invasion While Promoting Apoptosis Through Upregulation of Protein Tyrosine Phosphatase SHP-1 and Inhibition of STAT3 Phosphorylation.
    Jia WQ, Wang ZT, Zou MM, Lin JH, Li YH, Zhang L, Xu RX.
    Cell Physiol Biochem; 2018 May 03; 47(5):1871-1882. PubMed ID: 29961065
    [Abstract] [Full Text] [Related]

  • 17. (-)-Oleocanthal exerts anti-melanoma activities and inhibits STAT3 signaling pathway.
    Gu Y, Wang J, Peng L.
    Oncol Rep; 2017 Jan 03; 37(1):483-491. PubMed ID: 27878290
    [Abstract] [Full Text] [Related]

  • 18. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
    Chun J, Li RJ, Cheng MS, Kim YS.
    Cancer Lett; 2015 Feb 01; 357(1):393-403. PubMed ID: 25434800
    [Abstract] [Full Text] [Related]

  • 19. [Antitumor activity of lycorine in renal cell carcinoma ACHN cell line and its mechanism].
    Huang YQ, Zhang YM, Jin Z, Li XZ, Wang CS, Xu K, Huang P, Liu CX.
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun 01; 36(6):857-62. PubMed ID: 27320892
    [Abstract] [Full Text] [Related]

  • 20. Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma.
    Li X, Xu P, Wang C, Xu N, Xu A, Xu Y, Sadahira T, Araki M, Wada K, Matsuura E, Watanabe M, Zheng J, Sun P, Huang P, Nasu Y, Liu C.
    Oncotarget; 2017 Mar 28; 8(13):21177-21186. PubMed ID: 28416753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.